Tower Research Capital (TRC)’s ASP Isotopes ASPI Stock Holding History
Bought
Maintained
Sold
Other funds holding ASPI
ECA
VCM
RIM
ETC
AIC
Tower Research Capital (TRC)'s ASPI Position: Q1 2026 in Review
Tower Research Capital (TRC) increased its ASP Isotopes (ASPI) stake by 919% in Q1 2026, buying an estimated $88.4K and bringing the position to 16,578 shares worth $73.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2434.
Tower Research Capital (TRC) first reported a position in ASPI in Q3 2023 and has held it in 10 quarters since. The position peaked at $242K in Q3 2025. 177 funds tracked by Wall St. Rank hold ASPI as of Q1 2026.
- Tower Research Capital (TRC) held 16,578 shares of ASP Isotopes worth $73.3K as of Q1 2026.
- Tower Research Capital (TRC) bought 14,951 ASP Isotopes shares in Q1 2026, an estimated $88.4K.
- ASP Isotopes made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #2434 holding.
- Tower Research Capital (TRC) first reported a position in ASP Isotopes in Q3 2023 and has held it in 10 quarters since.
- Tower Research Capital (TRC)'s ASP Isotopes position peaked at $242K in Q3 2025.
- 177 funds tracked by Wall St. Rank held ASP Isotopes as of Q1 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.